We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fully Automated Analyzer Has Multiplex Capabilities

By LabMedica International staff writers
Posted on 16 Aug 2010
A state of the art analyzer offers complete consolidation of the patient's profile for clinical diagnostics. More...


The new advanced machine uses Biochip Array Technology and is capable of testing for multiple analytes simultaneously from a single sample, providing advanced test compilation, and patient profiling.

The Evidence Evolution analyzer provides limitless capabilities enabling simultaneous testing from a single small volume sample. A complete profile of biomarkers can be analyzed from as little as 7.0 µL of sample and the assay menu is extensive. The Evidence Evolution has the ability to process 2,940 tests per hour.

The analyzer was unveiled by Randox Laboratories Ltd. (Crumlin, UK), at the American Association Clinical Chemistry's Clinical Lab Expo in Anaheim (CA, USA) in July 2010. Multiplex testing allows multiple tests to be carried out from an undivided patient sample reducing the amount of time and labor spent on individual tests. True Random Access allows continuous reagents samples and consumable input and output without interrupting testing and batch samples are processed with instant STAT capabilities. The highly accurate testing is achieved by the use of linear Bio-drive Robotics, which delivers fast and highly precise operations with uncompromised quality. The unrivalled mechanical capabilities ensure continuous flow of results.

The array menus include clinical, immunoassays, molecular diagnostics, toxicology, and drug residue assays. The Evidence Evolution is suitable for clinical laboratories with medium to high throughput. The measurement principle is based on chemiluminescence with a 200-biochip capacity yielding up to 9,800 tests containing up to 20 different panels onboard simultaneously. The system also hosts high quality and highly secure remote access diagnostics, ensuring advanced technical support is never more than a click away.

Related Links:

Randox Laboratories Ltd.
American Association Clinical Chemistry




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.